32 unknown. 32 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 32 | Unknown 32 |
Follow Glaucoma: new trials by email Literature Review of Glaucoma trials Research Report on Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of NSAID vs. Steroid-NSAID Combo Post-Selective Laser Trabeculoplasty: Phase 4, Single-Center RCT Ketorolac 0.5% Eye Drops, Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops - Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Unknown | St. Joseph's Healthcare Hamilton | 126 | 2024-09-01 | 2024-07-12 |
| Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops. 20% ASED + AT, 0.9% NS + AT - Corneal Epitheliopathy, Glaucoma | Phase 4 | Unknown | Université de Sherbrooke | 25 | 2024-03-01 | 2024-03-05 |
| Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl Eybelis ophthalmic solution 0.002% - Normal Tension Glaucoma, Primary Open-angle Glaucoma | Phase 4 | Unknown | Santen Pharmaceutical Asia Pte. Ltd. | 150 | 2022-02-15 | 2022-03-15 |
| Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma Netarsudil Ophthalmic, Bimatoprost Ophthalmic - Normal Tension Glaucoma | Phase 4 | Unknown | Salus University | 115 | 2021-08-01 | 2021-08-06 |
| NSAID vs Steroid in Trabeculectomy Wound Management Bromfenac 0.07% Oph Susp, Dexamethasone - Glaucoma | Phase 4 | Unknown | Cindy Hutnik | 150 | 2020-11-01 | 2020-10-19 |
| Triamcinolone Injections for Persistent Choroidal Effusions Post Glaucoma Surgery Triamcinolone Acetonide 1 ml of 40 mg/mL suspension, Sham - Participants will not recieve the Triamcinolone Acetonide - Glaucoma, Choroidal Effusions | Phase 4 | Unknown | Sunnybrook Health Sciences Centre | 20 | 2020-10-14 | 2022-05-04 |
| 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration. tafluprost/timolol - Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Unknown | Fondazione G.B. Bietti, IRCCS | 43 | 2020-06-04 | 2022-03-29 |
| Comparing the Effectiveness of Phacoemulsification + ECP Laser and Phacoemulsification Alone for Glaucoma Patients Phacoemulsification+ Endoscopic cyclophotocoagulation (ECP) laser - Glaucoma Open-Angle Primary, Cataract | Phase 4 | Unknown | Guy's and St Thomas' NHS Foundation Trust | 160 | 2020-03-15 | 2020-03-04 |
| Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy. Voltaren Ophtha 1 mg/ml, GSK, Monopex 1 mg/ml, Théa - Glaucoma | Phase 4 | Unknown | Copenhagen University Hospital, Rigshospitalet | 70 | 2019-08-01 | 2022-10-26 |
| Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial Brimonidine Tartrate 1.5mg - Glaucoma, Ocular Hypertensive | Phase 4 | Unknown | CHA University | 61 | 2019-03-20 | 2020-12-01 |
| Efficacy and Safety of Latanoprost/Timolol for Primary Open Angle Glaucoma Latanoprost/Timolol - Primary Open Angle Glaucoma | Phase 4 | Unknown | Universiti Kebangsaan Malaysia Medical Centre | 40 | 2019-01-02 | 2019-09-23 |
| Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients. Xalost S, Xalatan, Taflotan-S - Glaucoma | Phase 4 | Unknown | Taejoon Pharmaceutical Co., Ltd. | 144 | 2018-12-19 | 2019-11-15 |
| CATS Tonometer IOP Reduction Latanoprost Verses Timolol CATS Tonometer, Latanoprost - Glaucoma; Drugs | Phase 4 | Unknown | Intuor Technologies, Inc. | 72 | 2018-07-01 | 2019-11-26 |
| Efficacy and Safety of XEN® Gel Stent and Post-operative Management in Patients With Open Angle Glaucoma 5-fluorouracil, Transconjunctival needling, Transconjunctival revision - Open-angle Glaucoma | Phase 4 | Unknown | Wroclaw Medical University | 100 | 2016-01-01 | 2022-03-29 |
| Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT Preservative-free latanoprost 50µg/ml, Preserved latanoprost 0.005% - Glaucoma, Ocular Hypertension | Phase 4 | Unknown | Medical University of Vienna | 70 | 2015-09-17 | 2022-04-07 |
| A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma Xalatan, Apo-Latanoprost, Co-Latanoprost - POAG, Primary Open Angle Glaucoma | Phase 4 | Unknown | Dr. David Yan | 60 | 2015-09-01 | 2017-07-26 |
| Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml Preserved Bimatoprost 0.01%, Tafluprost Unit Dose Preservative Free 15microgram/ml - Ocular Hypertension, Glaucoma | Phase 4 | Unknown | Universitaire Ziekenhuizen KU Leuven | 67 | 2015-09-01 | 2016-05-12 |
| Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves Aqueous Suppressant Eye Drops - Glaucoma | Phase 4 | Unknown | Credit Valley EyeCare | 150 | 2012-02-01 | 2017-07-21 |
| Comparison of the Ahmed Glaucoma Valve FP7 and FP8 in Pediatric Glaucoma FP7 Ahmed Glaucoma Drainage Implant, FP8 Glaucoma Drainage Implant - Pediatric Glaucoma | Phase 4 | Unknown | Federal University of São Paulo | 40 | 2011-12-01 | 2014-04-08 |
| Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma Artificial drainage implant - Glaucoma | Phase 4 | Unknown | Aurolab | 30 | 2011-07-01 | 2013-01-03 |
Showing 20 of 32. Sign in to see all of them.
Glaucoma, Open-Angle (8) · Ocular Hypertension (7) · Low Tension Glaucoma (3) · Cataract (2) · Choroidal Effusions (1) · Corneal Diseases (1) · Dry Eye Syndromes (1) · Eye Diseases (1) · Glaucoma, Angle-Closure (1) · Hydrophthalmos (1) · Hypertension (1) · Patient Compliance (1)
Eye Diseases (31) · Ocular Hypertension (25) · Optic Nerve Diseases (3) · Eye Abnormalities (2) · Lens Diseases (2) · Behavior (1) · Cardiovascular Diseases (1) · Choroid Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Glaucoma, Open-Angle (1) · Health Behavior (1) · Infant, Newborn, Diseases (1) · Lacrimal Apparatus Diseases (1)
Latanoprost (6) · Timolol (4) · Brimonidine Tartrate (3) · Bimatoprost (2) · Ophthalmic Solutions (2) · Trabeculectomy (2) · tafluprost (2) · Acetazolamide (1) · Brimonidine Tartrate, Timolol Maleate Drug Combination (1) · Dexamethasone (1) · Fluorometholone (1) · Fluorouracil (1) · Ketorolac (1) · Ketorolac Tromethamine (1) · Lasers (1)
National University Hospital, Singapore (2) · Aurolab (1) · CHA University (1) · Chinese University of Hong Kong (1) · Cindy Hutnik (1) · Copenhagen University Hospital, Rigshospitalet (1) · Credit Valley EyeCare (1) · Dr. David Yan (1) · Federal University of São Paulo (1) · Fondazione G.B. Bietti, IRCCS (1) · Genovate Biotechnology Co., Ltd., (1) · Glaukos Corporation (1) · Grewal Eye Institute (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Hotel Dieu Hospital (1)
Canada (5) · South Korea (4) · Austria (3) · India (3) · Italy (3) · United States (3) · Singapore (2) · Belgium (1) · Brazil (1) · Denmark (1) · Germany (1) · Hong Kong (1) · Israel (1) · Malaysia (1) · Poland (1)
Amandeep S Rai, MD (1) · Camila F Netto, MD (1) · Catherine M Birt, MD FRCSC (1) · Cindy Hutnik, MD (1) · Da-Wen Lu (1) · Daniella Bach-Holm, MD, Ph.D. (1) · David B Yan, M.D., F.R.C.S. (C) (1) · Devesh K Varma, MD FRCSC (1) · Dexter YL Leung, MRCS (1) · Dilraj S Grewal, MBBS (1) · Dr. Prashanth Ranganath, MBBS., MS., (1) · Enitan A Sogbesan, MD (1) · Francesco Oddone, MD (1) · Gagandeep S Brar, MD (1)
PMID 10937547, PMID 17122118, PMID 19882583, PMID 32884231, PMID 33818170, PMID 36602718, PMID 36912740